Satellite Biosciences, Inc.

CAMBRIDGE, MA · Founded 2019 · CIK 0001832180 · Biotech · Private

Engineered cells and cell therapies for treating difficult-to-address diseases

satellite.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$101M
2 Form D · Mar 2022
55 months since last filing
Contracts
—
No federal contracts on record
Patents
37
0 granted · 37 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$19,000,000
Private capital raisedForm D · SEC$82,470,989
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1254MIND BIOSCIENCES LLC——
1255TScan Therapeutics—$123M
1256Aardvark Therapeutics, Inc.—$103M
1257Satellite Biosciences, Inc.—$101M
1258GPN THERAPEUTICS, INC.——
1259AYTU BIOSCIENCE, INC—$26M
1260NANODESK, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 12 related persons
  • Sangeeta BhatiaPromoter
  • Sujata BhatiaDirector
  • Christopher ChenDirector · Promoter
  • Laura Lande-DinerExecutive Officer
  • David LennonDirector · Executive Officer
  • Thomas LoweryExecutive Officer
  • Diane MarcouExecutive Officer
  • Eileen McGuireDirector
  • Ellie McGuireDirector
  • Yair SchindelDirector
  • Ling WongDirector
  • William YoungDirector

Patents

USPTO · 0 granted of 37
  • Culture Media And Conditions For In Vitro Expansion Of Hepatocytesapplication
  • Culture Media And Conditions For In Vitro Expansion And/or Maturation Of Hepatocytesapplication
  • Engineered Tissue Constructs For The Treatment Of Hyperammonemiaapplication
  • Devices And Methods For Cell Aggregationapplication
  • Devices And Methods For Cell Encapsulationapplication
  • Methods Of Implanting Engineered Tissue Constructsapplication
  • Methods For Aggregating Cells In Suspensionapplication
  • Engineered Tissue Constructs And Uses Thereofapplication
  • Methods Of Implanting Engineered Tissue Constructsapplication
  • Hypoimmunogenic Cell Mixtures And Methods Of Use Thereofapplication
  • Devices And Methods For Cell Encapsulationapplication
  • Devices And Methods For Cell Aggregationapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.